Ricerca avanzata:
-
Delibere
DELIBERA n. 351/2018 del 28/06/2018
Autorizzazione alla conduzione dello Studio: “An international multi-centric observational study on the use of ruxolitinib in the treatment of patients with polycythemia vera resistant or intolerant to hydroxyurea”.Codice: CINC424BIC04. Presa d’atto contratto
-
Delibere
DELIBERA n. 350/2018 del 28/06/2018
Studio osservazionale: “A prospective Registry of patients with a confirmed diagnosis of adenocarcinoma of the prostate presenting with metastatic castrate-resistant prostate cancer”. Protocol 212082PCR4001. Cambio Principal Investigator.